89bio, Inc

+$0.19 (+7.28%) Today
$0.00 (0.00%) As of 8:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.

CEO
Rohan Palekar
Employees
41
Headquarters
San Francisco, California
Founded
2018

ETNB Key Statistics

Market cap
56.98M
Price-Earnings ratio
—
Dividend yield
—
Average volume
243.12K
High today
$2.82
Low today
$2.60
Open price
$2.62
Volume
261.51K
52 Week high
$22.31
52 Week low
$2.00

ETNB Earnings

-$1.41
-$0.94
-$0.47
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure